venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 7
- +1 vs. Q1 2026
- Portfolio value
- $519.4M
- +$238.8M (+85.1%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | COM | 4,643,430 | $160.6M | 30.9% | +4,126+0.1% | Added | History |
| PBLSParabilis Medicines, Inc. | Stock | 5,266,697 | $144.1M | 27.8% | +5,266,697 | New | History |
| ALMSAlumis Inc. | COM | 4,528,408 | $127.4M | 24.5% | 00.0% | Unchanged | History |
| ACHVAchieve Life Sciences, Inc. | COM | 5,914,720 | $38.6M | 7.4% | +5,914,720 | New | History |
| ALXOAlx Oncology Holdings Inc | COM | 12,884,638 | $26.7M | 5.1% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 472,194 | $17.2M | 3.3% | −17,000−3.5% | Reduced | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 337,697 | $4.74M | 0.9% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (1)
Positions held at the end of Q1 2026 that are gone from this filing.